Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Enhanced Dissolution Rate of Metformin HCl via GR-type Tablet with PAA and HPMC

PAA와 HPMC을 이용한 Metformin HCl 함유 GR 타입 정제에 의한 용출율 개선

  • Published : 2008.02.21
Download PDF
⟨ Previous Next ⟩

Abstract

To develop a novel metformin HCl-loaded GR type tablet, various tablets were compressed with poly acrylic acid (PAA) and hydroxypropylmethyl cellulose (HPMC) using a wet granulation, and their physical properties such as swelling rate, hardness and dissolution were then investigated. Among the formulae tested in this study, the tablet prepared with PAA 971 and 974 as disintegrants showed fastest dissolution rate and swelling rate. Furthermore, the tablets prepared with PAA and HPMC improved the swelling rate, hardness and dissolution compared to those prepared with only HPMC. Our results suggested that the tablets prepared with PAA 971, 974 and HPMC might be a potential candidate for gastric retention type tablets.

Keywords

References

  1. Deshpande, A.A., Rhodes, C.T., Shah, N.H. & Malick, A.W., Controlled-release drug delivery systems for prolonged gastric residence. an overview, Drug Dev. Ind. Pharm., 22(6), 531-539 (1996) https://doi.org/10.3109/03639049609108355
  2. Davis, S.S., Formulation strategies for absorption windows. Drug Dis. Today., 10, 249-256 (2005) https://doi.org/10.1016/S1359-6446(04)03351-3
  3. Klausner, E.A., Lavy, E., Friedman, M., Hoffman, A., Expandable gastroretentive dosage forms. J. Controlled. Release, 90, 143-162 (2003) https://doi.org/10.1016/S0168-3659(03)00203-7
  4. Frances, S., John, T.F., John, H.C., Luigi, G.M., Harbans, L.S. & Anne-Marie, S. The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state. J. Pharmaceutics, 308, 8-13 (2006) https://doi.org/10.1016/j.ijpharm.2005.09.036
  5. Mahesh, C., Paras, J., Sachin, C., Rajesh, S. & Pradeep, V., Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation. Int. J. Pharmaceutics, 304, 178-184 (2005) https://doi.org/10.1016/j.ijpharm.2005.08.009
  6. Antonio, A., Adriana, M.V., Edgard, F.C. & Joaquim, M., Effect of different types of fundoplication on the gastric emptying of liquids and gastric compliance in rats. J. Pediatric Surgery, 40, 1551-1556 (2005) https://doi.org/10.1016/j.jpedsurg.2005.06.006
  7. Emmanuel, B.S., Michel, A., Simon, R., Sophie, H., Guillaume, S., Eric L. & Philippe, D., Modalities in Performing Capsule Endoscopy: Does it Influence Gastric Retention? Gastrointestinal Endoscopy, 61, AB160 (2005)
  8. Joon Yun, A., Patrick, Y.L. & Kimberly, A.B., Clinical benefits of hydration and volume expansion in a wide range of illnesses may be attributable to reduction of sympathovagal ratio. Med.l Hypotheses, 64(3), 646-650 (2005) https://doi.org/10.1016/j.mehy.2004.07.014
  9. Torrado, S., Prada, P., Paloma M. de la Torre & Torrado, S., Chitosan-poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials, 25(5), 917-923 (2004) https://doi.org/10.1016/S0142-9612(03)00579-9
  10. Eytan, A., Klausner, E.L., Michael, F. & Amnon, H., Expandable gastroretentive dosage forms. J. Controlled Release, 90(2), 143-162 (2003) https://doi.org/10.1016/S0168-3659(03)00203-7
  11. Snoeck, V., Huyghebaert, N., Cox, E., Vermeire, A., Saunders, J., Remon, J. P., Verschooten, F. & Goddeeris, B.M., Gastrointestinal transit time of nondisintegrating radioopaque pellets in suckling and recently weaned piglets. J. Controlled Release, 94(1), 143-153 (2004) https://doi.org/10.1016/j.jconrel.2003.09.015
  12. Campbell, IW., Management of Type2 diabetes mellitus with special reference to Metformin HCl therapy. Diabetes Metabolism, 191-196 (1991)
  13. Groop, LC., Sulfonylureas in NIDDM. Diabetes care, 740-751 (1992)
  14. Davidson, MB., An overview of Metformin HCl in the treatment of Type2 diabetes mellitus. American J. Medicine, 99-110 (1997)
  15. Nattrass, M., Albert, KGMM., Biguanides. Diabetologia, 14, 17 (1978)
  16. DeFranzo, R.A., Pharmacologic therapy for type 2 diabetes mellitus. Annals of Int. Medicine, 281-303 (1999)
  17. Jun, Chen., William, E., Blevins, H.P. & Kinam, P., Gastric retention properties of superporous hydrogel composites. J. Controlled Release, 64(1-3), 39-51 (2000) https://doi.org/10.1016/S0168-3659(99)00139-X
  18. Brahma, N.S. & Kwon H, K., Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Controlled Release, 63(3), 235-259 (2000) https://doi.org/10.1016/S0168-3659(99)00204-7
  19. Thairs, S., Ruck, S., Jackson, S.J., Steele, R.J.C., Feely, L.C., Washington, C. & Washington, N., Effect of dose size, food and surface coating on the gastric residence and distribution of an ion exchange resin. Int. J. Pharmaceutics, 176(1), 47-53 (1998) https://doi.org/10.1016/S0378-5173(98)00305-6